| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |